BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
Live EA class + 6 months of EA OnDemand
  • Expert-led weekly online sessions
  • EA Masterclass access between classes
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

130-point score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

Because a manufacturer secures a patent for a pharmaceutical

Expert replies
by BTGmoderatorDC » Sun Dec 09, 2018 5:48 am

Timer

00:00

Answers

A

B

C

D

E

Stats

Difficulty

Because a manufacturer secures a patent for a pharmaceutical compound, the patent does not bar competitors from producing a chemical like it, as long as those chemicals have at least one structural difference with the patented compound.
(A) same as original
(B) That a manufacturer has secured a patent for one of its pharmaceutical compounds do not bar competitors from producing similar chemicals and having at least one important difference from the patented compound
(C) A patent for one of a manufacturer's pharmaceutical compounds does not bar competitors from producing a chemical like the patented compound, as long as the two differ structurally in at least one way
(D) When securing a patent for one of a manufacturer's pharmaceutical compounds, competitors are not barred from the production of chemicals such as the patented compound, provided that there is at least one structural difference
(E) Even if a manufacturer secures a patent for one of its pharmaceutical compounds, this does not bar competitors from the production of a chemical such as the patented compound, but having at least one structural difference from it

OA C

Source: Manhattan Prep
Join the discussion
Source: — Sentence Correction |

by deloitte247 » Tue Dec 11, 2018 2:05 am
Option A: Incorrect
The innate conjunction used here is faulty, and does not follow parallelism.

Option B: Incorrect
In this option, there is a problem with the subject-verb connection. That is, between the Manufacturer and producing similar chemicals.

Option C: correct
This option follows parallelism in the right syntax and everything is in proper order. Pronoun and conjunctions were well placed.

Option D: Incorrect
such is not the right idiom to introduce a patent substance, it is faulty.

Option E: Incorrect
This suffers same fate as option D above and also, this option a faulty pronoun usage.
Join the discussion

• Page 1 of 1